SARAH LOGAN: Open Payments
NPI 1275248080 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 80 payments from 19 companies in 2025. Trend: 2023 $966 · 2024 $1,890 · 2025 $1,587
Food & beverage: $1,587
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $287 |
| Novartis Pharmaceuticals Corporation | 11 | $244 |
| PFIZER INC. | 10 | $197 |
| Novo Nordisk Inc | 13 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
| Lilly USA, LLC | 5 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| CSL Behring | 2 | $51 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
Products named: LEQVIO, ELIQUIS, AIRSUPRA, Kerendia, FARXIGA, Rybelsus, XIFAXAN, Wegovy.
Industry payments across KY — which companies pay providers there.
